These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1280 related articles for article (PubMed ID: 26967761)

  • 21. The Other Nontuberculous Mycobacteria: Clinical Aspects of Lung Disease Caused by Less Common Slowly Growing Nontuberculous Mycobacteria Species.
    Yan M; Brode SK; Marras TK
    Chest; 2023 Feb; 163(2):281-291. PubMed ID: 36174743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010004. PubMed ID: 28000919
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
    Kim SY; Shin SJ; Jeong BH; Koh WJ
    BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of species change of Nontuberculous Mycobacteria during or after treatment.
    Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ
    BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece - relation to microbiological data.
    Manika K; Tsikrika S; Tsaroucha E; Karabela S; Karachaliou I; Bosmi I; Kioumis I; Papavasileiou A
    Future Microbiol; 2015; 10(8):1301-6. PubMed ID: 26226382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
    Gitti Z; Mantadakis E; Maraki S; Samonis G
    Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
    Guglielmetti L; Mougari F; Lopes A; Raskine L; Cambau E
    Future Microbiol; 2015; 10(9):1467-83. PubMed ID: 26344005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical characteristics and drug susceptibility test of nontuberculous mycobacterial lung disease].
    Lou H; Sun Q; Gu J; Yang H; Hao XH; Xiao HP; Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):901-906. PubMed ID: 31826533
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.
    Henriette Zweijpfenning SM; Chiron R; Essink S; Schildkraut J; Akkerman OW; Aliberti S; Altenburg J; Arets B; van Braeckel E; Delaere B; Gohy S; Haarman E; Lorent N; McKew G; Morgan L; Wagner D; van Ingen J; Hoefsloot W
    Chest; 2022 Jul; 162(1):76-81. PubMed ID: 35063454
    [No Abstract]   [Full Text] [Related]  

  • 31. Nontuberculous Mycobacterial Infections in a French Hospital: A 12-Year Retrospective Study.
    Blanc P; Dutronc H; Peuchant O; Dauchy FA; Cazanave C; Neau D; Wirth G; Pellegrin JL; Morlat P; Mercié P; Tunon-de-Lara JM; Doutre MS; Pélissier P; Dupon M
    PLoS One; 2016; 11(12):e0168290. PubMed ID: 27959960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
    Haworth CS; Floto RA
    Thorax; 2017 Nov; 72(11):969-970. PubMed ID: 29054887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.
    Khan O; Chaudary N
    Drug Des Devel Ther; 2020; 14():2287-2294. PubMed ID: 32606598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases.
    Huh HJ; Kim SY; Jhun BW; Shin SJ; Koh WJ
    Infect Genet Evol; 2019 Aug; 72():169-182. PubMed ID: 30315892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
    Koh WJ; Jeong BH; Kim SY; Jeon K; Park KU; Jhun BW; Lee H; Park HY; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Kim H; Kwon OJ
    Clin Infect Dis; 2017 Feb; 64(3):309-316. PubMed ID: 28011608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
    Knoll BM; Kappagoda S; Gill RR; Goldberg HJ; Boyle K; Baden LR; Fuhlbrigge AL; Marty FM
    Transpl Infect Dis; 2012 Oct; 14(5):452-60. PubMed ID: 22676720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical aspects in patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex, in the Brazilian Amazon.
    Monteiro JTC; Lima KVB; Barretto AR; Furlaneto IP; Gonçalves GM; Costa ARFD; Lopes ML; Dalcolmo MP
    J Bras Pneumol; 2018 Apr; 44(2):93-98. PubMed ID: 29791556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ECCMID 2018 meeting report: the continuing clinical challenge of nontuberculous mycobacteria lung disease.
    Mason I
    Future Microbiol; 2018 Sep; 13():1347-1349. PubMed ID: 30256153
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease.
    Kang HK; Park HY; Kim D; Jeong BH; Jeon K; Cho JH; Kim HK; Choi YS; Kim J; Koh WJ
    BMC Infect Dis; 2015 Feb; 15():76. PubMed ID: 25887191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.